ARTICLE | Finance
Lilly's venture molecules
Lilly commits excess assets and up to $150M to three VC funds
September 13, 2010 7:00 AM UTC
After engaging in a VC beauty contest, Eli Lilly and Co. (NYSE:LLY) has picked three new venture funds to seed with the pharma's excess molecules as well as cash.
Each venture firm has agreed to cap its fund at $250 million and Lilly has committed to provide up to 20% of the total capital in each fund, spokesperson Mark Taylor told Ebb & Flow...